Abstract
1 At higher temperatures, near the physiological range for mammals and nonhibernating frogs, the adrenoceptors for both inotropic responses to adrenaline and noradrenaline and for cyclic 3′,5′-adenosine monophosphate (cyclic AMP) production in rat and frog isolated heart preparations, had typical β characteristics. Phenoxybenzamine potentiated the inotropic response and the accumulation of cyclic AMP; conversely, propranolol inhibited the two responses.
2 When the ambient temperature was reduced, the adrenoceptors mediating cyclic AMP production changed very little; they were blocked as effectively as at the higher temperature by propranolol and were not blocked by phenoxybenzamine. However, the adrenoceptors mediating the inotropic response were markedly changed by the decrease in temperature; phenoxybenzamine now inhibited this response and the inhibitory activity of propranolol was reduced about tenfold.
3 These results indicate that the adrenoceptors that mediate cardiac inotropic responses at physiological temperatures are distinct from those that mediate the production of cyclic AMP, and that the activation of adenylate cyclase and the accumulation of cyclic AMP are probably not intermediate steps in cardiac inotropic responses to catecholamines.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Benfey B. G., Varma D. R. Interactions of sympathomimetic drugs, propranolol and phentolamine, on atrial refractory period and contractility. Br J Pharmacol Chemother. 1967 Aug;30(3):603–611. doi: 10.1111/j.1476-5381.1967.tb02166.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brooker G. High pressure anion exchange chromatographic measurement of cyclic adenosine 3',5'-monophosphate and cyclic (14C) adenosine monophosphate specific activity in myocardium prelabeled with (14C) adenosine. J Biol Chem. 1971 Dec 25;246(24):7810–7816. [PubMed] [Google Scholar]
- Buckley G. A., Jordan C. C. Temperature modulation of alpha- and beta-adrenoceptors in the isolated frog heart. Br J Pharmacol. 1970 Feb;38(2):394–398. [PMC free article] [PubMed] [Google Scholar]
- FURCHGOTT R. F. The receptors for epinephrine and norepinephrine (adrenergic receptors). Pharmacol Rev. 1959 Jun;11(2 Pt 2):429–442. [PubMed] [Google Scholar]
- Govier W. C. Myocardial alpha adrenergic receptors and their role in the production of a positive inotropic effect by sympathomimetic agents. J Pharmacol Exp Ther. 1968 Jan;159(1):82–90. [PubMed] [Google Scholar]
- Krishna G., Weiss B., Brodie B. B. A simple, sensitive method for the assay of adenyl cyclase. J Pharmacol Exp Ther. 1968 Oct;163(2):379–385. [PubMed] [Google Scholar]
- Kunos G., Szentivanyi M. Evidence favouring the existence of a single adrenergic receptor. Nature. 1968 Mar 16;217(5133):1077–1078. doi: 10.1038/2171077a0. [DOI] [PubMed] [Google Scholar]
- Kunos G., Yong M. S., Nickerson M. Transformation of adrenergic receptors in the myocardium. Nat New Biol. 1973 Jan 24;241(108):119–120. doi: 10.1038/newbio241119a0. [DOI] [PubMed] [Google Scholar]
- Lee T. P., Kuo J. F., Greengard P. Regulation of myocardial cyclic AMP by isoproterenol, glucagon and acetylcholine. Biochem Biophys Res Commun. 1971 Nov;45(4):991–997. doi: 10.1016/0006-291x(71)90435-9. [DOI] [PubMed] [Google Scholar]
- McNeill J. H., Davis R. S., Muschek L. D. Phenylephrine effects on cardiac contractility adenyl cyclase, and phosphorylase. Arch Int Pharmacodyn Ther. 1972 Jun;197(2):317–327. [PubMed] [Google Scholar]
- Sobel B. E., Mayer S. E. Cyclic adenosine monophosphate and cardiac contractility. Circ Res. 1973 Apr;32(4):407–414. doi: 10.1161/01.res.32.4.407. [DOI] [PubMed] [Google Scholar]
- Wenzel D. G., Su J. L. Interactions between sympathomimetic amines and blocking agents on the rat ventricle strip. Arch Int Pharmacodyn Ther. 1966 Apr;160(2):379–389. [PubMed] [Google Scholar]